The Way We Walked with Immunology

Literature Cited

1. Ishizaka K, Ishizaka T, Campbell DH. 1.  1959. The biological activity of soluble antigen-antibody complexes: II. Physical properties of soluble complexes having skin-irritating activity. J. Exp. Med. 109:127–43 [Google Scholar]
2. Ishizaka K, Ishizaka T, Campbell DH. 2.  1959. Biologic activity of soluble antigen-antibody complexes: III. Various antigen-antibody systems and the possible role of complement. J. Immunol. 83:105–15 [Google Scholar]
3. Ishizaka T, Ishizaka K. 3.  1959. Biological activities of aggregated gamma globulin: I. Skin-reactive and complement-fixing properties of heat-aggregated gamma globulin. Proc. Soc. Exp. Biol. Med. 101:845–50 [Google Scholar]
4. Ishizaka K, Ishizaka T. 4.  1960. Biological activity of aggregated γ-globulin: II. Study of various methods for aggregation and species differences. J. Immunol. 85:163–71 [Google Scholar]
5. Ishizaka T, Ishizaka K, Borsos T. 5.  1961. Biological activity of aggregated γ-globulin: IV. Mechanisms of complement fixation. J. Immunol. 87:433–38 [Google Scholar]
6. Porter RR. 6.  1959. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain. Biochem. J. 73:119–26 [Google Scholar]
7. Ishizaka K, Ishizaka T. 7.  1964. Molecular basis of passive sensitization: II. The role of fragment III of γ-globulin and its disulfide bonds in passive sensitization and complement fixation. J. Immunol. 93:59–68 [Google Scholar]
8. Prausnitz K, Küstner H. 8.  1921. Studien über die Überempfindlichkeit. Zbl. Bakt. 86:160–69 [Google Scholar]
9. Heremans JF, Vaerman J-P. 9.  1962. β_2A globulin as a possible carrier of allergic reaginic activity. Nature 193:1091–92 [Google Scholar]
10. Ishizaka K, Ishizaka T, Lee EH, Fudenberg H. 10.  1965. Immunochemical properties of human γA isohemagglutinin: I. Comparisons with γG- and γM-globulin antibodies. J. Immunol. 95:197–208 [Google Scholar]
11. Ishizaka K, Ishizaka T. 11.  1966. Physicochemical properties of reaginic antibody: III. Further studies on the reaginic antibody in γA-globulin preparations. J. Allergy 38:108–19 [Google Scholar]
12. Ishizaka K, Ishizaka T, Hornbrook MM. 12.  1966. Physico-chemical properties of human reaginic antibody: IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J. Immunol. 97:75–85 [Google Scholar]
13. Ishizaka K, Ishizaka T, Hornbrook MM. 13.  1966. Physicochemical properties of reaginic antibody: V. Correlation of reaginic activity with γE-globulin antibody. J. Immunol. 97:840–53 [Google Scholar]
14. Ishizaka K, Ishizaka T, Hornbrook MM. 14.  1967. Allergen-binding activity of γE, γG and γA antibodies in sera from atopic patients: in vitro measurements of reaginic antibody. J. Immunol. 98:490–501 [Google Scholar]
15. Ishizaka K, Ishizaka T. 15.  1967. Identification of γE-antibodies as a carrier of reaginic activity. J. Immunol. 99:1187–98 [Google Scholar]
16. Johansson SG, Bennich H. 16.  1967. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 13:381–94 [Google Scholar]
17. Bennich H, Ishizaka K, Ishizaka T, Johansson SG. 17.  1969. A comparative antigenic study of γE-globulin and myeloma-IgND. J. Immunol. 102:826–31 [Google Scholar]
18. Ishizaka K, Ishizaka T. 18.  1968. Reversed type allergic skin reactions by anti-γE-globulin antibodies in humans and monkeys. J. Immunol. 100:554–62 [Google Scholar]
19. Ishizaka T, Ishizaka K, Johansson SGO, Bennich H. 19.  1969. Histamine release from human leukocytes by anti-λE antibodies. J. Immunol. 102:884–92 [Google Scholar]
20. Ishizaka T, Ishizaka K, Orange RP, Austen KF. 20.  1970. The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. J. Immunol. 104:335–43 [Google Scholar]
21. Ishizaka K, Tomioka H, Ishizaka T. 21.  1970. Mechanisms of passive sensitization: I. Presence of IgE and IgG molecules on human leukocytes. J. Immunol. 105:1459–67 [Google Scholar]
22. Tomioka H, Ishizaka K. 22.  1971. Mechanisms of passive sensitization: II. Presence of receptors for IgE on monkey mast cells. J. Immunol. 107:971–78 [Google Scholar]
23. Ishizaka K, Ishizaka T, Lee EH. 23.  1970. Biologic function of the Fc fragments of E myeloma protein. Immunochemistry 7:687–94 [Google Scholar]
24. Ishizaka T, Ishizaka K, Tomioka H. 24.  1972. Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells. J. Immunol. 108:513–20 [Google Scholar]
25. Kishimoto T, Ishizaka K. 25.  1972. Regulation of antibody response in vitro: IV. Heavy chain antigenic determinants on hapten-specific memory cells. J. Immunol. 109:1163–73 [Google Scholar]
26. Kishimoto T, Ishizaka K. 26.  1973. Regulation of antibody response in vitro: VI. Carrier-specific helper cells for IgG and IgE antibody response. J. Immunol. 111:720–32 [Google Scholar]
27. Kishimoto T, Ishizaka K. 27.  1973. Regulation of antibody response in vitro: VII. Enhancing soluble factors for IgG and IgE antibody response. J. Immunol. 111:1194–205 [Google Scholar]
28. Kishimoto T. 28.  1985. Factors affecting B-cell growth and differentiation. Annu. Rev. Immunol. 31:133–57 [Google Scholar]
29. Ishizaka K, Kishimoto T, Delespesse G, King TP. 29.  1974. Immunogenic properties of modified antigen E: I. Presence of specific determinants for T cells in denatured antigen and polypeptide chains. J. Immunol. 113:70–77 [Google Scholar]
30. Ishizaka K. 30.  1988. IgE-binding factors and regulation of the IgE antibody response. Annu. Rev. Immunol. 6:513–34 [Google Scholar]
31. Ishizaka T, Ishizaka K. 31.  1975. Biology of immunoglobulin E: molecular basis of reaginic hypersensitivity. Prog. Allergy 19:60–121 [Google Scholar]
32. Ishizaka T, Chang TH, Taggart M, Ishizaka K. 32.  1977. Histamine release from rat mast cells by antibodies against rat basophilic leukemia cell membrane. J. Immunol. 119:1589–96 [Google Scholar]
33. Conrad DH, Froese A, Ishizaka T, Ishizaka K. 33.  1978. Evidence for antibody activity against the receptor for IgE in a rabbit antiserum prepared against IgE-receptor complexes. J. Immunol. 120:507–12 [Google Scholar]
34. Ishizaka T, Ishizaka K. 34.  1978. Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors. J. Immunol. 120:800–5 [Google Scholar]
35. Ishizaka T, Okudaira H, Mauser LE, Ishizaka K. 35.  1976. Development of rat mast cells in vitro: I. Differentiation of mast cells from thymus cells. J. Immunol. 116:747–54 [Google Scholar]
36. Ishizaka T, Adachi T, Chang T-H, Ishizaka K. 36.  1977. Development of mast cells in vitro: II. Biologic function of cultured mast cells. J. Immunol. 118:211–17 [Google Scholar]
37. Ishizaka T, Dvorak AM, Conrad DH, Niebyl JR, Marquette JP, Ishizaka K. 37.  1985. Morphologic and immunologic characterization of human basophils developed in cultures of cord blood mononuclear cells. J. Immunol. 134:532–40 [Google Scholar]
38. Furitsu T, Saito H, Dvorak AM, Schwartz LB, Irani AM. 38.  et al. 1989. Development of human mast cells in vitro. PNAS 86:10039–43 [Google Scholar]
39. Mitsui H, Furitsu T, Dvorak AM, Irani A-MA, Schwartz LB. 39.  et al. 1993. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. PNAS 90:735–39 [Google Scholar]
40. Saito H, Ebisawa M, Tachimoto H, Shichijo M, Fukagawa K. 40.  et al. 1996. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J. Immunol. 157:343–50 [Google Scholar]
41. Suzuki H, Takei M, Yanagida M, Nakahata T, Kawakami T, Fukamachi H. 41.  1997. Early and late events in FcεR1 signal transduction in human cultured mast cells. J. Immunol. 159:5881–88 [Google Scholar]